<DOC>
	<DOCNO>NCT02932475</DOCNO>
	<brief_summary>Purpose : The objective proposal study safety efficacy metformin add insulin treatment type 2 diabetes mellitus ( T2DM ) among pregnant woman . Participants : 1200 pregnant woman type 2 diabetes complicate pregnancy 10 U.S. clinical center Procedures ( method ) : Pregnant woman T2DM 10 week 20 week 6 day singleton fetus randomize insulin/placebo versus insulin/metformin . Primary outcome composite adverse neonatal outcome ( clinically relevant hypoglycemia , birth trauma , hyperbilirubinemia , stillbirth/neonatal death ) . Study visit monthly clinical visit ; blood draw 24-30 week . Maternal infant outcome chart abstract .</brief_summary>
	<brief_title>Medical Optimization Management Type 2 Diabetes Complicating Pregnancy ( MOMPOD )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Pregnancy Complications</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Maternal age 1845 year Singleton pregnancy know fetal anomaly Gestational age 10weeks 0 day 20 week 6 day menstrual dating confirm ultrasound , ultrasound alone Clinical diagnosis preexist T2DM require medical treatment ( oral agent insulin ) Clinical diagnosis diabetes diagnose 10 week &lt; 20 week 6 day gestation Willing start insulin therapy discontinue oral hypoglycemic pill study pill Able swallow pill Clinical diagnosis preexist renal disease , define creatinine &gt; 1.5 mg/dL Clinical history lactic acidosis Known allergy metformin Participation another study could affect primary outcome Delivery plan nonMOMPOD study location Unwillingness use insulin treatment follow prenatal care doctor 's instruction insulin blood glucose monitoring</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>